Studies have revealed increased numbers of ILC2s in the esophagus of active pediatric EoE patients compared with healthy controls, alongside increased levels of IL-33, a key activator of ILC2s, and IL-13, a cytokine produced by ILC2s [11, 31]. Here, IL13 is linked to eosinophilic esophagitis.